Prognostic value of immunohistochemical expression of the c-erbB-2 oncoprotein in metastasic prostate cancer
Open Access
- 20 August 1999
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 84 (4) , 421-425
- https://doi.org/10.1002/(sici)1097-0215(19990820)84:4<421::aid-ijc16>3.0.co;2-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Elevated serum levels of p105erbB-2 in patients with advanced-stage prostatic adenocarcinomaInternational Journal of Cancer, 1996
- Overexpression of her-2/neu in human prostate cancer and benign hyperplasiaCancer Letters, 1996
- In vivo amplification of the androgen receptor gene and progression of human prostate cancerNature Genetics, 1995
- Proto-Oncogenes and Tumor Suppressor Genes in Human Urological MalignanciesJournal of Urology, 1994
- Expression of the c-erbB-2 (Her-2/neu) Oncoprotein in Human Prostatic CarcinomaJournal of Urology, 1993
- Overexpression of Her-2/Neu may be an Indicator of Poor Prognosis in Prostate CancerJournal of Urology, 1993
- Prognostic value of c-erbB-2 expression in uterine cervical carcinoma.Journal of Clinical Pathology, 1992
- Expression of c‐erb B‐2/neu proto‐oncogene in human prostatic cancer tissues and cell linesMolecular Carcinogenesis, 1992
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Overexpression of the c‐erbB‐2 protein in human breast tumor cell linesJournal of Cellular Biochemistry, 1989